Literature DB >> 24409403

Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy.

Parisa Lotfinegad1, Karim Shamsasenjan2, Aliakbar Movassaghpour3, Jafar Majidi1, Behzad Baradaran1.   

Abstract

Immunosuppressive ability of mesenchymal stem cells (MSCs), their differentiation properties to various specialized tissue types, ease of in vitro and in vivo expansion and specific migration capacity, make them to be tested in different clinical trials for the treatment of various diseases. The immunomodulatory effects of MSCs are less identified which probably has high clinically significance. The clinical trials based on primary research will cause better understanding the ability of MSCs in immunomodulatory applications and site specific migration in the optimization of therapy. So, this review focus on MSCs functional role in modulating immune responses, their ability in homing to tumor, their potency as delivery vehicle and their medical importance.

Entities:  

Keywords:  Cell migration; Cell therapy; Immunomodulation; Mesenchymal stem cells

Year:  2013        PMID: 24409403      PMCID: PMC3885369          DOI: 10.5681/apb.2014.002

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  122 in total

1.  The therapeutic potential of dental pulp cells: more than pulp fiction?

Authors:  Stan Gronthos
Journal:  Cytotherapy       Date:  2011-11       Impact factor: 5.414

2.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

3.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

4.  Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.

Authors:  Mariam A Stoff-Khalili; Angel A Rivera; J Michael Mathis; N Sanjib Banerjee; Amanda S Moon; A Hess; Rodney P Rocconi; T Michael Numnum; M Everts; Louise T Chow; Joanne T Douglas; Gene P Siegal; Zeng B Zhu; Hans Georg Bender; Peter Dall; Alexander Stoff; Larissa Pereboeva; David T Curiel
Journal:  Breast Cancer Res Treat       Date:  2007-01-13       Impact factor: 4.872

5.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

6.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

7.  Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.

Authors:  Fabio Morandi; Lizzia Raffaghello; Giovanna Bianchi; Francesca Meloni; Annalisa Salis; Enrico Millo; Soldano Ferrone; Vincenzo Barnaba; Vito Pistoia
Journal:  Stem Cells       Date:  2008-02-21       Impact factor: 6.277

8.  Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.

Authors:  Ryosuke Uchibori; Takashi Okada; Takayuki Ito; Masashi Urabe; Hiroaki Mizukami; Akihiro Kume; Keiya Ozawa
Journal:  J Gene Med       Date:  2009-05       Impact factor: 4.565

9.  Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).

Authors:  Philippe Bourin; Bruce A Bunnell; Louis Casteilla; Massimo Dominici; Adam J Katz; Keith L March; Heinz Redl; J Peter Rubin; Kotaro Yoshimura; Jeffrey M Gimble
Journal:  Cytotherapy       Date:  2013-04-06       Impact factor: 5.414

10.  Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate.

Authors:  Chiara Capelli; Elisa Gotti; Marina Morigi; Cinzia Rota; Ling Weng; Francesco Dazzi; Orietta Spinelli; Giovanni Cazzaniga; Rosangela Trezzi; Andrea Gianatti; Alessandro Rambaldi; Josee Golay; Martino Introna
Journal:  Cytotherapy       Date:  2011-03-18       Impact factor: 5.414

View more
  29 in total

Review 1.  Secretion of immunoregulatory cytokines by mesenchymal stem cells.

Authors:  Dobroslav Kyurkchiev; Ivan Bochev; Ekaterina Ivanova-Todorova; Milena Mourdjeva; Tsvetelina Oreshkova; Kalina Belemezova; Stanimir Kyurkchiev
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

2.  Recombinant laminin α5 LG1-3 domains support the stemness of human mesenchymal stem cells.

Authors:  Sujin Lee; Dong-Sung Lee; Jun-Hyeog Jang
Journal:  Exp Ther Med       Date:  2020-12-21       Impact factor: 2.447

3.  Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy.

Authors:  Davod Pashoutan Sarvar; Karim Shamsasenjan; Parvin Akbarzadehlaleh
Journal:  Adv Pharm Bull       Date:  2016-09-25

Review 4.  MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.

Authors:  Jivan Qasim Ahmed; Sazan Qadir Maulud; Manish Dhawan; Om Prakash Choudhary; Paywast Jamal Jalal; Rezhna Kheder Ali; Gahin Abdulraheem Tayib; Dlshad Abdullah Hasan
Journal:  J Infect Public Health       Date:  2022-06-21       Impact factor: 7.537

Review 5.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

6.  Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions.

Authors:  Amir Kol; Soraya Foutouhi; Naomi J Walker; Nguyet T Kong; Bart C Weimer; Dori L Borjesson
Journal:  Stem Cells Dev       Date:  2014-06-26       Impact factor: 3.272

Review 7.  The Effect of Hypoxia on Mesenchymal Stem Cell Biology.

Authors:  Mostafa Ejtehadifar; Karim Shamsasenjan; Aliakbar Movassaghpour; Parvin Akbarzadehlaleh; Nima Dehdilani; Parvaneh Abbasi; Zahra Molaeipour; Mahshid Saleh
Journal:  Adv Pharm Bull       Date:  2015-06-01

8.  Effects of diagnostic ultrasound-targeted microbubble destruction on the homing ability of bone marrow stromal cells to the kidney parenchyma.

Authors:  Gong Wang; Qian Zhang; Zhongxiong Zhuo; Shengzheng Wu; Zheng Liu; Hongmei Xia; Kaibin Tan; Linru Zou; Ling Gan; Yunhua Gao
Journal:  Eur Radiol       Date:  2015-12-04       Impact factor: 5.315

Review 9.  Methods of Liver Stem Cell Therapy in Rodents as Models of Human Liver Regeneration in Hepatic Failure.

Authors:  Nasser Hashemi Goradel; Masoud Darabi; Karim Shamsasenjan; Mostafa Ejtehadifar; Sarah Zahedi
Journal:  Adv Pharm Bull       Date:  2015-09-19

10.  Intra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; Christopher M Ferguson; Scott M Riester; Andre J van Wijnen; Amir Lerman; Lilach O Lerman
Journal:  Stem Cell Res Ther       Date:  2015-01-19       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.